Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients
Antimicrobial Agents and Chemotherapy, 05/15/2012
Clinical Article
Molto J et al. – The GMRs for darunavir coadministered with silymarin relative to darunavir alone were 0.86 (90% CI, 0.70 to 1.05) for the area under the concentration–time curve from 0 to 12 h, 0.83 (90% CI, 0.80 to 0.98) for the maximum concentration, and 0.94 (90% CI, 0.73 to 1.19) for the concentration at the end of the dosing interval. In summary, coadministration of silymarin with darunavir–ritonavir seems to be safe in HIV–infected patients; no dose adjustment for darunavir–ritonavir seems to be necessary.
